SEC 13F Intelligence

Neuberger Berman Group LLC / PFE

Neuberger Berman Group LLC’s Pfizer Inc Position

Does Neuberger Berman Group LLC own Pfizer Inc (PFE)? Yes — 9.69M shares worth $272M (+0.21% of its 13F portfolio) as of Q1 2026, up from 7.36M shares the prior filed quarter.

Position Value
$272M
Q1 2026
Shares
9.69M
% of Portfolio
+0.21%
Quarters Held
30
currently held

Position History PFE

Reported value by quarter
Q4 ’18: $582MQ4 ’18Q1 ’19: $527MQ2 ’19: $504MQ3 ’19: $377MQ4 ’19: $342MQ4 ’19Q1 ’20: $261MQ2 ’20: $239MQ3 ’20: $249MQ4 ’20: $231MQ4 ’20Q1 ’21: $189MQ2 ’21: $334MQ3 ’21: $401MQ4 ’21: $556MQ4 ’21Q1 ’22: $518MQ2 ’22: $640MQ3 ’22: $581MQ4 ’22: $632MQ4 ’22Q1 ’23: $563MQ2 ’23: $504MQ3 ’23: $565MQ4 ’23: $510MQ4 ’23Q1 ’24: $423MQ2 ’24: $386MQ3 ’24: $404MQ4 ’24: $131MQ4 ’24Q1 ’25: $48MQ2 ’25: $72MQ3 ’25: $229MQ4 ’25: $183MQ4 ’25Q1 ’26: $272Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20269.69M$272M+0.21%
Q4 20257.36M$183M+0.14%
Q3 20259.01M$229M+0.17%
Q2 20252.97M$72M+0.06%
Q1 20251.91M$48M+0.04%
Q4 20244.95M$131M+0.10%
Q3 202413.95M$404M+0.31%
Q2 202413.80M$386M+0.32%
Q1 202415.25M$423M+0.35%
Q4 202317.70M$510M+0.44%
Q3 202317.04M$565M+0.51%
Q2 202313.74M$504M+0.45%
Q1 202313.80M$563M+0.52%
Q4 202212.34M$632M+0.62%
Q3 202213.27M$581M+0.61%
Q2 202212.21M$640M+0.64%
Q1 202210.00M$518M+0.44%
Q4 20219.50M$556M+0.44%
Q3 20219.38M$401M+0.35%
Q2 20218.56M$334M+0.29%
Q1 20215.24M$189M+0.18%
Q4 20206.28M$231M+0.24%
Q3 20206.78M$249M+0.29%
Q2 20207.31M$239M+0.30%
Q1 20208.01M$261M+0.40%
Q4 20198.72M$342M+0.40%
Q3 201910.50M$377M+0.46%
Q2 201911.64M$504M+0.60%
Q1 201912.41M$527M+0.65%
Q4 201813.34M$582M+0.81%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Neuberger Berman Group LLC’s full portfolio or all institutional holders of PFE.